AstraZeneca to buy China-based Gracell Biotechnologies in $1.2 billion deal
AstraZeneca has carefully maneuvered through the complex pharmaceutical market, announcing intentions to pay up to $1.2 ...
Read moreAstraZeneca has carefully maneuvered through the complex pharmaceutical market, announcing intentions to pay up to $1.2 ...
Read moreAstraZeneca is looking forward to spin off its business operations in China and rather list it ...
Read moreThe Consumer Technology Association is working hard to ensure that CES 2022 remains a live event. ...
Read moreTech and Business News from around the world. Follow along for latest in the world of Tech, AI, Crypto, EVs, Business Personalities and more.
reach us at [email protected]